Skip to main content
. 2019 May 10;15(19):2211–2225. doi: 10.2217/fon-2019-0180

Figure 1. . Kaplan-Meier plot of overall survival for patients with stable, treated brain metastases in the BEACON Phase III trial.

Figure 1. 

EP: Etirinotecan pegol; HR: Hazard ratio; OS: Overall survival; TPC: Treatment of physician's choice.

Created using data from Shah et al. [54].